Resources Top 5: Fin joins Canada’s gold rush as Whitebark and Terra surge on strong results
Health Check: CSL is not out of the woods yet, bearish analysts warn
Amazon bets on nuclear to power AI future as Australia dithers
Lunch Wrap: ASX ruffled by hot CPI surprise, CSL dumps again
The smarter solution for anyone retiring with a home loan
Argonaut Algorithm: The big takeaways from gold’s quarterly season and a spooky Halloween buy
StockTake: Ark Mines on rare earth rails for Sandy Mitchell development
The greatest Australian national park you’ve never heard of
Top 10 at 11: ASX wobbles as quarterlies come thick and fast
Biocurious: Drug developers are hedging their bets on long and winding approval journey
Contributors
Our Resident Experts
Mining
Argonaut Algorithm: The big takeaways from gold’s quarterly season and a spooky Halloween buy
Resources Top 5: Mount Ridley sprints ahead in the gallium race, surging 140pc
Beyond the Degrussa Era: Why ASX explorers believe the Bryah Basin’s best days lie ahead
How Black Rock Mining’s graphite strategy is sliding into place at Mahenge
Resources Top 5: Cazaly cops speeding ticket as gold, silver and rare earths keep on truckin’
Tech
‘Just do it again’: Nike launches ‘anti-gravity’ shoe tech to reclaim market edge
Three ways to manage risk when investing in real estate private credit
Stealing from the Louvre? In this economy, go for it
Ovanti targets major fintech deals at Money20/20 conference in Las Vegas
Fear and distrust are hampering Victoria’s tech future: KordaMentha report
Featured in Tech
Health & Biotech
Biocurious: Drug developers are hedging their bets on long and winding approval journey
EZZ Life Science and the Aussie contenders chasing America’s wellness craze
Health Check: CSL shares tumble after recovery proves to be a false dawn
Dr Boreham’s Crucible: Bcal scores a diagnostic hat-trick with new cancer blood tests
Health Check: Cashed-up clinical-stage biotechs are poised to go all the way
Featured in Health & Biotech
Experts
Precision Points: Investors need to pay attention when a company makes this key announcement
Stock Tips: Analysts turn to safe hands and travel plans in rough seas
The superannuation hotspots with the highest average balances
The three fears stalking investors right now – but why calm heads will prevail
Big super’s unprecedented bets in Trump’s America face rising risks
Criterion: Look beyond this year’s AGM theatrics to the underlying earnings messages
Too big to invest: $4.3 trillion super savings outgrow Australia
